Treatment Patterns and Survival Outcomes in a Real-World Cohort of 263 Patients with EGFR L858R-Mutant Non-Small Cell Lung Cancer: Focus on EGFR-TKI Selection
{{output}}
Aim: Compare the treatment efficacy of EGFR TKIs in patients with non-small cell lung cancer with the EGFR L858R exon 21 mutation. Materials and methods: ... ...
